CNS activity of poziotinib in NSCLC with exon 20 insertion mutations.

被引:11
作者
Le, Xiuning
Garassino, Marina Chiara
Cornelissen, Robin
Socinski, Mark A.
Tchekmedyian, Nishan
Molina, Julian R.
Baik, Christina S.
Leu, Sharon
Dreiling, Lyndah
Lebel, Francois M.
Clarke, Jeffrey Melson
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] IRCCS, Natl Canc Inst, Dept Med Oncol, Milan, Italy
[3] Erasmus MC, Rotterdam, Netherlands
[4] Advent Hlth Hematol & Oncol, Orlando, FL USA
[5] Pacif Shores Med Grp, Huntington Beach, CA USA
[6] Mayo Clin, Rochester, MN USA
[7] Seattle Canc Care Alliance, Seattle, WA USA
[8] Spectrum Pharmaceut, Irvine, CA USA
[9] Duke Univ, Med Ctr, Durham, NC USA
关键词
D O I
10.1200/JCO.2021.39.15_suppl.9093
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9093
引用
收藏
页数:2
相关论文
共 50 条
[31]   Efficacy and Safety of Poziotinib in HER2 Exon 20 Insertion NSCLC Patients who Received at Least 2 Previous Systemic Therapies [J].
Le, X. ;
Prelaj, A. ;
Baik, C. ;
Tchekmedyian, N. ;
Leu, S. ;
Bhat, G. ;
Heymach, J. V. ;
Cornelissen, R. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S147-S148
[32]   Preliminary Results of a Phase II Study of Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC [J].
Elamin, Y. ;
Robichaux, J. ;
Heymach, J. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) :S1536-S1536
[33]   LNG-451, a potent inhibitor of EGFR exon 20 insertion mutations with high CNS exposure [J].
Pearson, Paul G. ;
Pandey, Anjali ;
Roth, Bruce ;
Saxton, Tracy ;
Estes, Daniel J. ;
Trivedi, Ravi ;
Agrawal, Himanshu ;
Hallur, Gurulingappa ;
Ahmad, Ishtiyaque ;
Jenkins, Helen ;
Murray, Brion W. .
CANCER RESEARCH, 2022, 82 (12)
[34]   Characterization of EGFR Exon 18 and 20 Mutations in NSCLC [J].
Farooqi, M. ;
Oliver, D. .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06) :757-757
[35]   Efficacy and safety of sunvozertinib in treatment naive NSCLC patients with EGFR exon20 insertion mutations [J].
Xu, Yan ;
Yang, James Chih-Hsin ;
Chiu, Chao-Hua ;
Hsu, Ping-Chih ;
Mitchell, Paul ;
Chang, Chia Lun ;
John, Tom ;
Bazhenova, Lyudmila ;
Kim, Tae Min ;
Yip, Ching Wan ;
Wang, Mengzhao ;
Janne, Pasi A. ;
Zhou, Caicun .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[36]   Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations [J].
Yang, J. C-H. ;
Wang, M. ;
Chiu, C-H. ;
Hsu, P-C. ;
Mitchell, P. ;
Chang, C. L. ;
Kim, T. M. ;
John, T. ;
Greillier, L. ;
Bazhenova, L. ;
Carcereny, E. ;
Spira, A. I. ;
Shim, B. ;
Lee, K. H. ;
Cobo Dols, M. ;
Ghiringhelli, F. ;
Yip, C. W. ;
Xiong, J. ;
Janne, P. A. ;
Zhou, C. .
ANNALS OF ONCOLOGY, 2023, 34
[37]   Sunvozertinib for the treatment of NSCLC with EGFR Exon20 insertion mutations: The first pivotal study results [J].
Wang, Mengzhao ;
Fan, Yun ;
Sun, Meili ;
Wang, Yongsheng ;
Zhao, Yanqiu ;
Jin, Bo ;
Hu, Ying ;
Han, Zhigang ;
Song, Xia ;
Liu, Anwen ;
Tang, Kejing ;
Ding Cuimin ;
Liang, Li ;
Wu, Lin ;
Gao, Junzhen ;
Wang, Jianghong ;
Cheng, Ying ;
Zhou, Jianying ;
He, Yong ;
Zheng, Li .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[38]   EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy [J].
Park, J. ;
Song, J. -Y. ;
Sung, M. ;
Kwon, M. J. ;
Kim, C. R. ;
Shin, Y. K. ;
Choi, Y. -L. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S484-S484
[39]   Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC [J].
Saw, S. P. L. ;
Tan, A. ;
Chen, J. ;
Lai, G. ;
Hlaing, N. O. ;
Takano, A. ;
Lau, D. ;
Yeong, J. ;
Lim, K. H. ;
Skanderup, A. ;
Chan, J. ;
Teh, Y. L. ;
Rajasekaran, T. ;
Jain, A. ;
Tan, W. L. ;
Ng, Q. S. ;
Kanesvaran, R. ;
Lim, W. -T. ;
Tan, E. H. ;
Ang, M. -K. ;
Tan, D. S. W. .
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S605-S605
[40]   Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC [J].
Ou, Sai-Hong Ignatius ;
Hong, Jin-Liern ;
Christopoulos, Petros ;
Lin, Huamao M. ;
Vincent, Sylvie ;
Churchill, Eric N. ;
Soeda, Junpei ;
Kazdal, Daniel ;
Stenzinger, Albrecht ;
Thomas, Michael .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) :744-754